Press Releases
Mar. 28, 2026
Kayseri Pastirma Gains EU Protection
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 27, 2026
EU EXTERNAL PARTNERS: Large-scale movements of people from Lebanon to Syria ― NGOs urge Libya to accept migration-related recommendations from UN human rights review ― EU and Nigeria sign ‘readmission’ agreement ― Prominent human rights activist jaile…
Gov't Institution
European Council on Refugees and Exiles (ECRE)
Owner: ECRE (Non-profit)
Mar. 27, 2026
EU launches safeguard investigation on grain-oriented electrical steel
Indeterminate
World Trade Organization
Mar. 26, 2026
EU Commission Pushes for Stronger Support for Energy-Poor Households
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 26, 2026
EU Urges Israel to Halt Hostilities in Lebanon
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 24, 2026
Costa Rica Achieves Historic First With Nation’s Inaugural Export of GACP-Certified Medical Cannabis to the European Union
Indeterminate
GlobeNewswire, Inc.
Mar. 25, 2026
EU Condemns Israel's Death Penalty Bill
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 25, 2026
EU Official Rules Out Ukraine Membership by 2027
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 25, 2026
EU Criticizes US Over Iran Strike Without Coordination with European Partners
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 25, 2026
EU, UK Mobilize Forces Near Cyprus Following Middle East Escalation
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 24, 2026
EU Hails Nigeria as Africa's Anchor Against Terror
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 26, 2026
Chinese Army to Hold Talks with EU, NATO Next Week
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 24, 2026
EU Spirulina Extract Market Analysis 2026–2036: Industry to Reach USD 256.3 Million by 2036 at 6.0% CAGR
Neutral
EIN Presswire
Mar. 25, 2026
Ghana Enters Landmark EU Defense Partnership
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 25, 2026
Ghana, EU Strike USD57.9M Defense Deal
Indeterminate
MENAFN
Owner: Sawsan Dababneh
Mar. 25, 2026
Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease
Indeterminate
GlobeNewswire, Inc.